Guardant Health
GH
#1787
Rank
C$15.41 B
Marketcap
C$117.54
Share price
-3.96%
Change (1 day)
81.96%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): C-$4.60

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is C-$4.60. In 2024 the company made an earnings per share (EPS) of C-$4.95 an increase over its 2023 EPS that were of C-$5.95.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$4.60-7.06%
2024C-$4.95-16.82%
2023C-$5.95-33.13%
2022C-$8.8960%
2021C-$5.5655.04%
2020C-$3.58207.14%
2019C-$1.17-19.81%
2018C-$1.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
C-$3.86-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C-$2.97-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA